DOSING REGIMEN FOR TREATING INFLUENZA VIRUS DISEASES

The present invention pertains to a dosing regimen for treating influenza virus diseases, and more specifically, to a method for treating influenza virus-related diseases through the administration of a mixed composition of monoclonal antibodies having a neutralizing activity against the influenza A...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	AN, Hyun Chul, KIM, Sung Hyun, JEON, Da Bee, LEE, Sang Joon, LEE, Se Won
Format:	Patent
Sprache:	eng ; fre ; kor
Schlagworte:	CHEMISTRY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The present invention pertains to a dosing regimen for treating influenza virus diseases, and more specifically, to a method for treating influenza virus-related diseases through the administration of a mixed composition of monoclonal antibodies having a neutralizing activity against the influenza A virus. The treatment method according to the present invention enables influenza A virus-related diseases to be treated through the intravenous administration of a mixed composition of monoclonal antibodies having a neutralizing activity against the influenza A virus. In addition, the treatment method according to the present invention can satisfy unmet medical needs for biological therapeutic agents for influenza virus-related diseases. La présente invention concerne un régime posologique pour traiter des maladies du virus de la grippe, et plus spécifiquement, une méthode pour traiter des maladies liées au virus de la grippe par administration d'une composition mélangle d'anticorps monoclonaux ayant une activité neutralisante contre le virus de la grippe A. La méthode de traitement selon la présente invention permet de traiter des maladies liées au virus de la grippe A par administration intraveineuse d'une composition mélangée d'anticorps monoclonaux ayant une activité neutralisante contre le virus de la grippe A. De plus, la méthode de traitement selon la présente invention peut satisfaire des besoins médicaux non satisfaits pour des agents thérapeutiques biologiques destinés à des maladies liées au virus de la grippe. 본 발명은 인플루엔자 바이러스 질환을 치료하기 위한 투여 요법에 관한 것으로, 인플루엔자 A 바이러스에 대하여 중화 활성을 갖는 단일클론 항체들의 혼합 조성물을 투여하여 인플루엔자 바이러스 관련 질환을 치료하는 방법에 관한 것이다. 본 발명에 따른 치료방법은 인플루엔자 A 바이러스에 대하여 중화 활성을 갖는 단일클론 항체들의 혼합 조성물을 정맥 내 투여하여 인플루엔자 A 바이러스 관련 질환이 치료될 수 있도록 한다. 또한 본 발명에 따른 치료방법은 인플루엔자 바이러스 관련 질환의 생물학적 치료제에 대한 미충족 의학적 요구(unmet medical need)를 충족시킬 수 있다.